NCT06408870View on ClinicalTrials.gov

A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

August 28, 2024

Study Completion Date

August 28, 2024

Conditions
Healthy
Interventions
DRUG

BI 1015550

BI 1015550

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06408870 - A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body | Biotech Hunter | Biotech Hunter